Thermo Fisher Scientific (TMO) is expected to report Q2 earnings before market open Thursday, July 24, with a conference call scheduled for 9:00 am ET.
Analysts are looking for a profit of 77c on revenue of $2.62B. The consensus is 74c to 79c for EPS, and revenue of $2.60B to $2.65B, according to First Call. The company beat analysts estimates for Q1 EPS, reporting 74c vs. a consensus of 72c. Thermo Fisher gave FY08 EPS guidance of $3.07 to $3.17; consensus at that time was $3.13.
Positives for this quarter's earnings include diverse geographic coverage and stable end-markets, with particular strength in Lab Products and Services. Possible negatives for earnings could be a slowdown in pharmaceutical company cap-ex spending. On July 7, Baird recommended buying shares of Thermo Fisher given its solid 2008 outlook and solid end markets.